NO20034171D0 - Biguanidderivater - Google Patents

Biguanidderivater

Info

Publication number
NO20034171D0
NO20034171D0 NO20034171A NO20034171A NO20034171D0 NO 20034171 D0 NO20034171 D0 NO 20034171D0 NO 20034171 A NO20034171 A NO 20034171A NO 20034171 A NO20034171 A NO 20034171A NO 20034171 D0 NO20034171 D0 NO 20034171D0
Authority
NO
Norway
Prior art keywords
biguanidderivater
hyperglycaemia
diabetes
meanings
compounds
Prior art date
Application number
NO20034171A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034171L (no
Inventor
Gerard Moinet
Daniel Cravo
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20034171D0 publication Critical patent/NO20034171D0/no
Publication of NO20034171L publication Critical patent/NO20034171L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Lubricants (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
NO20034171A 2001-03-21 2003-09-19 Biguanidderivater NO20034171L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0103846A FR2822464B1 (fr) 2001-03-21 2001-03-21 Derives biguanides et leurs applications en therapeutique
PCT/EP2002/003119 WO2002074740A1 (fr) 2001-03-21 2002-03-20 Derives de biguanide

Publications (2)

Publication Number Publication Date
NO20034171D0 true NO20034171D0 (no) 2003-09-19
NO20034171L NO20034171L (no) 2003-09-19

Family

ID=8861407

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034171A NO20034171L (no) 2001-03-21 2003-09-19 Biguanidderivater

Country Status (21)

Country Link
US (1) US7285681B2 (fr)
EP (1) EP1370525B1 (fr)
JP (1) JP4418157B2 (fr)
KR (1) KR20030085558A (fr)
CN (1) CN1228325C (fr)
AT (1) ATE449066T1 (fr)
AU (1) AU2002308178B2 (fr)
BR (1) BR0208131A (fr)
CA (1) CA2441309C (fr)
CZ (1) CZ20032766A3 (fr)
DE (1) DE60234424D1 (fr)
ES (1) ES2336771T3 (fr)
FR (1) FR2822464B1 (fr)
HU (1) HUP0303593A3 (fr)
MX (1) MXPA03008404A (fr)
NO (1) NO20034171L (fr)
PL (1) PL362528A1 (fr)
RU (1) RU2276136C2 (fr)
SK (1) SK12802003A3 (fr)
WO (1) WO2002074740A1 (fr)
ZA (1) ZA200308146B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101417988B (zh) * 2007-10-24 2011-04-27 山东轩竹医药科技有限公司 双胍哌嗪类二肽酰肽酶ⅳ抑制剂
KR101041428B1 (ko) * 2008-10-13 2011-06-14 한국화학연구원 Ｎ1-2-티오펜-2-일에틸-ｎ2-치환된 바이구아나이드 유도체,이의 제조방법 및 이를 유효성분으로 함유하는 약학 조성물
WO2010103040A1 (fr) 2009-03-10 2010-09-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Activateurs de protéine kinases activées par le 5'-adénosine monophosphate (ampk), destinés au traitement de l'hypertension pulmonaire
KR101136045B1 (ko) * 2009-11-16 2012-04-18 한국화학연구원 Ｎ1-(펜에틸)-ｎ2-치환된 바이구아나이드 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 약학 조성물
NL1037643C2 (en) * 2010-01-22 2011-07-25 Karel Paul Bouter Nutritional product comprising a biguanide.
KR101324283B1 (ko) * 2010-04-27 2013-11-01 한올바이오파마주식회사 바이구아나이드 화합물의 신규 염, 그의 제조방법, 그를 포함하는 약제학적 조성물
WO2013188452A1 (fr) * 2012-06-11 2013-12-19 The Regents Of The University Of California Composés et procédés de traitement du cancer
KR102216701B1 (ko) 2014-11-20 2021-02-18 이뮤노메트테라퓨틱스 인코포레이티드 바이구아나이드 화합물 및 이의 용도
CN107635963B (zh) 2015-04-30 2020-11-20 伊谬诺米特医疗有限公司 胍化合物及其用途
CN105125689B (zh) * 2015-09-21 2018-01-19 株洲千金药业股份有限公司 一种含有妇科千金片药渣的足浴粉及其制备方法
WO2018058109A1 (fr) * 2016-09-26 2018-03-29 Nusirt Sciences, Inc. Compositions et méthodes pour le traitement de troubles métaboliques
CN113354561B (zh) * 2021-04-17 2023-03-28 中山大学 双胍衍生物及其应用与制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB852584A (en) * 1956-05-31 1960-10-26 Us Vitamin Corp Biguanide compositions
US2937173A (en) * 1959-05-06 1960-05-17 Us Vitamin Pharm Corp Indolino and tetrahydroquinolino triazines
US3879541A (en) 1970-03-03 1975-04-22 Bayer Ag Antihyperglycemic methods and compositions
DE2009743A1 (de) * 1970-03-03 1971-09-16 Farbenfabriken Bayer Ag, 5090 Leverkusen Substituierte Biguanide mit antihyperglykämischer Wirkung
US3960949A (en) 1971-04-02 1976-06-01 Schering Aktiengesellschaft 1,2-Biguanides
EP0034002A3 (fr) 1980-01-22 1981-09-23 Beecham Group Plc Dérivés de carboxamidine
JPS6141367A (ja) * 1984-08-02 1986-02-27 三菱瓦斯化学株式会社 繊維または繊維製品の過酸化水素による漂白法
FR2696740B1 (fr) * 1992-10-13 1994-12-30 Dospharma Sa Dérivés prodrogués de la diméthylbiguanide et applications comme médicaments.

Also Published As

Publication number Publication date
ZA200308146B (en) 2005-01-20
ATE449066T1 (de) 2009-12-15
RU2003130070A (ru) 2005-04-10
WO2002074740A1 (fr) 2002-09-26
KR20030085558A (ko) 2003-11-05
CN1228325C (zh) 2005-11-23
ES2336771T3 (es) 2010-04-16
FR2822464B1 (fr) 2004-08-06
CA2441309C (fr) 2010-06-15
HUP0303593A2 (hu) 2004-03-01
SK12802003A3 (sk) 2004-02-03
CZ20032766A3 (cs) 2004-01-14
FR2822464A1 (fr) 2002-09-27
HUP0303593A3 (en) 2007-03-28
US20040092495A1 (en) 2004-05-13
BR0208131A (pt) 2004-03-02
US7285681B2 (en) 2007-10-23
EP1370525B1 (fr) 2009-11-18
RU2276136C2 (ru) 2006-05-10
NO20034171L (no) 2003-09-19
AU2002308178B2 (en) 2007-03-01
JP2004523580A (ja) 2004-08-05
CA2441309A1 (fr) 2002-09-26
PL362528A1 (en) 2004-11-02
DE60234424D1 (en) 2009-12-31
CN1496347A (zh) 2004-05-12
HK1062172A1 (en) 2004-10-21
MXPA03008404A (es) 2004-01-29
JP4418157B2 (ja) 2010-02-17
EP1370525A1 (fr) 2003-12-17

Similar Documents

Publication Publication Date Title
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
MX2007006397A (es) Derivados de tetrahidropirano.
AP2002002578A0 (en) Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses.
DK1613304T3 (da) DPP-IV-inhibitorer
CY1108808T1 (el) Ενωσεις μοτιλιδης
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
ATE381596T1 (de) Azo verbindung
ATE449066T1 (de) Biguanidderivate
DE50209545D1 (de) Flüssigkristallines medium
ATE457977T1 (de) Biguanidderivate
TR200101978T2 (tr) 3,3-Biarilpiperidin ve 2,2-biarilmorfolin türevleri.
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
SE9903290D0 (sv) Novel compounds
DE60202669D1 (de) 6-phenylbenzonaphthyidine
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
MX2008001778A (es) Combinacion de un agente hipnotico y un compuesto de bis arilo y heteroarilo sustituido y aplicacion terapeutica de la misma.
DE60215918D1 (de) Azofarbstoffe
DE60105618D1 (de) Dihydroporphyrinderivate und ihre verwendung
MXPA04000876A (es) Derivados de acido butirico.
DE602004009313D1 (de) Organosiliziumverbindungen und deren verwendung
DE60318033D1 (de) Biguanid-derivate und deren verwendung als antidiabetika
ATE348803T1 (de) Tryptase-inhibitoren
WO2005108355A3 (fr) Dihydrobenzothiophene
PT1140932E (pt) Derivados de 1,8-benzonaftiridina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application